Early-phase expansion in an age of cut backs
30 June 2011 | Jonathan Hare Scrip Clinical Research
Quintiles shuts Indian Phase I facility amid 'challenging environment' BI sees 1H growth, oncology promise, but Spiriva gap looms More chaos for InVivo as CFO leaves Spectrum acquires Talon, plans late 2013 Marqibo launch
Other Features & Analysis
Moses makes his mark EU medical device regulatory reform vote delay is a good thing German medtech has its say as health minister reaches “interesting” 100 days EU in disarray: what's happening to the single market?